WolverHeme Happy Hour

Welcome to WolverHeme Happy Hour! This is a podcast dedicated to all things hematology! We discuss new data, debate controversial therapies, and talk about new and exciting research. While we nerd out about data, we'll have a few drinks!Disclaimer: The views and opinions expressed on this podcast are solely those of the podcasters and guests and do not reflect the views or opinions of our employers or other affiliations.

Dex and the Cytokine City: Managing CRS with Bispecifics
Apr 7, 2025 – 00:59:51
LFGooo! The Rise, the Fall, and the Resurrection of Gemtuzumab in AML
Mar 11, 2025 – 01:04:35
Episode 32: Navigating a BlinatumoMAD World
Jan 21, 2025 – 01:06:04
The Aquila Study: Blowing Hot Air or a Soaring Success for Smoldering Multiple Myeloma
Jan 15, 2025 – 00:49:29
Pour Decisions, or ASH-olutely Fabulous? Reviewing 2024 ASH Lymphoma Updates
Dec 24, 2024 – 01:03:46
A Bunch of ASHholes Discuss Myeloma Abstracts
Nov 16, 2024 – 00:56:21
Cast your vote! Nivolumab vs. Brentuximab for Classical Hodgkin Lymphoma
Nov 8, 2024 – 00:48:07
Episode 27: Mantle Cell Masterclass with Tycel Phillips
Oct 10, 2024 – 01:01:12
Houston, we don't have a problem... with APOLLO
Aug 28, 2024 – 00:58:37
From Ancient Remedies to Modern Miracles: The Evolution of APL Treatment
Jun 13, 2024 – 00:58:05
Episode 24: Myeloma Madness with the Myeloma Man
Apr 17, 2024 – 00:58:33
Anthony and Bernie get rich on no-larabine! An ASH 2023 ALL discussion
Jan 25, 2024 – 00:57:49
LymphOMG: Pouring Over Lymphoma Abstracts from ASH
Dec 29, 2023 – 01:12:38
AMLchemy at ASH: Brewing Success with Menin Magic, MRD Mysteries, and Aza/Ven Alchemy
Dec 19, 2023 – 00:41:13
ASH Pregaming - Myeloma Madness with Manni and Papa Heme
Dec 1, 2023 – 00:52:20
AML Maintenance Part 2: a metaMORPHOsis?
Nov 8, 2023 – 00:54:30
AML Maintenance Part 1: Set Your QUAZARs to Stun
Oct 25, 2023 – 00:51:39
Episode 17: The Hemophilia Eras Tour
Aug 23, 2023 – 01:39:13
Common Sense Oncology: Outcomes That Matter
Aug 1, 2023 – 00:37:41
All too well: the reality of leukemia treatment
Jun 8, 2023 – 00:49:29
Episode 14: A Quantum Leap in AML Treatment? Dissecting Quizartinib Data with Dr. Dale Bixby
May 9, 2023 – 01:10:20
Episode 13: You get blinatumomab! You get blinatumomab!
Feb 24, 2023 – 01:08:03
Episode 12: Tinder for T Cells - Bispecifics in DLBCL
Feb 8, 2023 – 00:58:28
Episode 11: "Olu the Drunk Snowman" - IDH inhibitors in R/R AML with Dr. Jill Lykon
Jan 21, 2023 – 00:52:30
Episode 10: ASH Recap Part 2 - Papa Heme + WolverHeme
Dec 21, 2022 – 01:13:04
Episode 9: ASH Recap Part 1 - Dauno-Double Trouble
Dec 14, 2022 – 00:40:04
Episode 8: Pulling the Goalie on FLT3 Inhibitor Use in AML - A Discussion with Dr. Dale Bixby
Nov 23, 2022 – 01:22:13
Episode (3+)7: Straight Outta Roswell - OG AML Data
Oct 7, 2022 – 00:47:55
Episode 6: Dr. StrangeDrug or: How I Learned to Stop Worrying and Love the Asparaginase
Jul 21, 2022 – 01:15:43
Episode 5: IDH Inhibitors in AML: not so AGILE
Jun 3, 2022 – 01:24:43
Episode 4: All Aboard the Oncology StewardSHIP
May 27, 2022 – 00:55:29
Episode 3.2: Ranting About Rituximab in Acute Lymphoblastic Leukemia
Apr 22, 2022 – 00:50:03
Episode 3.1: History of Acute Lymphoblastic Leukemia Treatment and Building the BFM Backbone
Apr 22, 2022 – 00:46:59
Episode 2: We Don't Talk About Rylaze
Mar 18, 2022 – 00:44:33
Episode 1: Surrogate Endpoints in AML
Mar 11, 2022 – 00:25:44

Recent Reviews

12);;6

Solid Liquid Onc Content

It’s Friday and I don’t have a great pun ready but can’t wait to listen on my run home and then do my own happy hour. Top notch